DiscoverDaily Medical NewsISCHEMIA heart disease trial makes waves; feds want transparent health pricing
ISCHEMIA heart disease trial makes waves; feds want transparent health pricing

ISCHEMIA heart disease trial makes waves; feds want transparent health pricing

Update: 2019-11-19
Share

Description

ISCHEMIA trial hailed as practice changing

By Bruce Jancin


The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves.

 

You can take the MDedge Podcasts survey by clicking here.

 

Other news:

Feds propose new price transparency rules in health care

The goal of the proposal is to give consumers enough information to shop around for medical services.

 

Most charity assistance programs do not cover prescriptions for uninsured patients

Cancer or cancer-related treatments were covered by 41% of programs, and 34% provided assistance for genetic or rare diseases.

 

DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics

Further analyses from the DAPA-HF trial showed dapagliflozin cut death and heart failure events in HFrEF patients with no diabetes.

 

Suicide screening crucial in pediatric medical settings

Screening can take as little as 20 seconds.

 

You can contact the MDedge Daily Medical News by emailing us at podcasts@mdedge.com or following us on Twitter at @MDedgeTweets.

 

 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ISCHEMIA heart disease trial makes waves; feds want transparent health pricing

ISCHEMIA heart disease trial makes waves; feds want transparent health pricing

MDedge